Login
Home
Charts
Search
Watchlist
Products

Onyx Biotec Ltd

ONYX·NSE
₹37.000.00%Mon, 21 Sept '26
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Onyx Biotec Ltd

ONYX
NSE
₹37.00
0.00%
|Mon, 21 Sept '26
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹67Cr
Close
Close Price
₹37.00
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
—
PS
Price To Sales
0.97
Revenue
Revenue
₹69Cr
Rev Gr TTM
Revenue Growth TTM
12.14%
PAT Gr TTM
PAT Growth TTM
-104.23%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
243030323535
Growth YoY
Revenue Growth YoY%
26.26.514.79.7
Expenses
ExpensesCr
202524273432
Operating Profit
Operating ProfitCr
356512
OPM
OPM%
14.316.518.914.62.87.0
Other Income
Other IncomeCr
001000
Interest Expense
Interest ExpenseCr
111111
Depreciation
DepreciationCr
112221
PBT
PBTCr
345412
Tax
TaxCr
001100
PAT
PATCr
2232-11
Growth YoY
PAT Growth YoY%
86.9-3.0-130.1-65.0
NPM
NPM%
6.76.89.96.2-2.62.0
EPS
EPS₹
0.00.00.01.3-0.50.4
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
243030323535
Growth YoY
Revenue Growth YoY%
26.26.514.79.7
Expenses
ExpensesCr
202524273432
Operating Profit
Operating ProfitCr
356512
OPM
OPM%
14.316.518.914.62.87.0
Other Income
Other IncomeCr
001000
Interest Expense
Interest ExpenseCr
111111
Depreciation
DepreciationCr
112221
PBT
PBTCr
345412
Tax
TaxCr
001100
PAT
PATCr
2232-11
Growth YoY
PAT Growth YoY%
86.9-3.0-130.1-65.0
NPM
NPM%
6.76.89.96.2-2.62.0
EPS
EPS₹
0.00.00.01.3-0.50.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
4539546269
Growth
Revenue Growth%
-12.036.115.312.1
Expenses
ExpensesCr
3935455266
Operating Profit
Operating ProfitCr
648103
OPM
OPM%
12.611.315.516.74.9
Other Income
Other IncomeCr
0001
Interest Expense
Interest ExpenseCr
11221
Depreciation
DepreciationCr
11233
PBT
PBTCr
43460
Tax
TaxCr
01120
PAT
PATCr
32450
Growth
PAT Growth%
-45.097.036.3-104.2
NPM
NPM%
7.54.76.88.0-0.3
EPS
EPS₹
2.81.63.03.3-0.1
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
4539546269
Growth
Revenue Growth%
-12.036.115.312.1
Expenses
ExpensesCr
3935455266
Operating Profit
Operating ProfitCr
648103
OPM
OPM%
12.611.315.516.74.9
Other Income
Other IncomeCr
0001
Interest Expense
Interest ExpenseCr
11221
Depreciation
DepreciationCr
11233
PBT
PBTCr
43460
Tax
TaxCr
01120
PAT
PATCr
32450
Growth
PAT Growth%
-45.097.036.3-104.2
NPM
NPM%
7.54.76.88.0-0.3
EPS
EPS₹
2.81.63.03.3-0.1

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
661318
Reserves
ReservesCr
10121237
Current Liabilities
Current LiabilitiesCr
10202326
Non Current Liabilities
Non Current LiabilitiesCr
10202610
Total Liabilities
Total LiabilitiesCr
37597491
Current Assets
Current AssetsCr
14153049
Non Current Assets
Non Current AssetsCr
22444542
Total Assets
Total AssetsCr
37597491
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
661318
Reserves
ReservesCr
10121237
Current Liabilities
Current LiabilitiesCr
10202326
Non Current Liabilities
Non Current LiabilitiesCr
10202610
Total Liabilities
Total LiabilitiesCr
37597491
Current Assets
Current AssetsCr
14153049
Non Current Assets
Non Current AssetsCr
22444542
Total Assets
Total AssetsCr
37597491

Cash Flow

Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0221-1
Investing Cash Flow
Investing Cash FlowCr
-6-23-31-5
Financing Cash Flow
Financing Cash FlowCr
516352
Net Cash Flow
Net Cash FlowCr
0-417-5
Free Cash Flow
Free Cash FlowCr
-5-21-22-6
CFO To PAT
CFO To PAT%
14.5106.041.728.6711.5
CFO To EBITDA
CFO To EBITDA%
8.643.818.213.7-44.0
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0221-1
Investing Cash Flow
Investing Cash FlowCr
-6-23-31-5
Financing Cash Flow
Financing Cash FlowCr
516352
Net Cash Flow
Net Cash FlowCr
0-417-5
Free Cash Flow
Free Cash FlowCr
-5-21-22-6
CFO To PAT
CFO To PAT%
14.5106.041.728.6711.5
CFO To EBITDA
CFO To EBITDA%
8.643.818.213.7-44.0

Ratios

Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1056267
Price To Earnings
Price To Earnings
21.3
Price To Sales
Price To Sales
1.70.91.0
Price To Book
Price To Book
1.91.11.2
EV To EBITDA
EV To EBITDA
10.523.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.543.731.435.1
OPM
OPM%
12.611.315.516.74.94.9
NPM
NPM%
7.54.76.88.0-0.3-0.3
ROCE
ROCE%
15.16.511.812.4
ROE
ROE%
20.510.114.48.9
ROA
ROA%
9.13.14.95.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1056267
Price To Earnings
Price To Earnings
21.3
Price To Sales
Price To Sales
1.70.91.0
Price To Book
Price To Book
1.91.11.2
EV To EBITDA
EV To EBITDA
10.523.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.543.731.435.1
OPM
OPM%
12.611.315.516.74.94.9
NPM
NPM%
7.54.76.88.0-0.3-0.3
ROCE
ROCE%
15.16.511.812.4
ROE
ROE%
20.510.114.48.9
ROA
ROA%
9.13.14.95.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Onyx Biotec Ltd

  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/vkyfwkwtpclyh5h38pc6psps.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/ebm05g9m11egd2r2z2h5go6n.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/d5e3iqxmf2wu2euanp3u23n0.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/kp5htactus8u89y2r5fk3v6d.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/3xvihxag3080ol2nlhhtgi02.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies